Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC

Condition:   Head and Neck Squamous Cell Carcinoma
Intervention:   Drug: Durvalumab Plus Tremelimumab
Sponsor:   Samsung Medical Center
Not yet recruiting

http://ift.tt/2HWQ3hR